Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Iron levels affect sleep apnea severity in people with hair loss, especially women.

Early hair loss may indicate prostate issues.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Severe hair loss may worsen with skin condition, suggesting treating the skin might help.

CAR is a useful marker for assessing alopecia areata severity.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Lower survivin levels in blood are linked to more severe and progressing alopecia areata.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Trichoscopy is better than the hair pull test for tracking alopecia areata.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

PRP therapy effectively treats alopecia areata and atrophic acne scars.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

The FDA approved a new Pfizer drug for hair loss in teens.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

A combination of cyclosporine and oral corticosteroid successfully regrew hair in a 19-year-old with alopecia universalis.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Ayurvedic treatment led to complete hair regrowth in a patient with Alopecia Areata.